Venlafaxine Hydrochloride
Product Images NDC 68071-1728

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68071-1728). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 1728 9)

Label for Venlafaxine Hydrochloride 75mg extended-release capsules from NuCare Pharmaceuticals, Inc. It indicates a package containing 90 capsules. The label includes the product number R1621090, prescription-only status, and storage instructions to keep at controlled temperature 68-77°F. It also has warnings to keep out of reach of children and advises contacting a doctor for side effects.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 01)

A scatter plot illustrating the pharmacokinetic fold change and 90% confidence interval recommendations for venlafaxine hydrochloride when interacting with various drugs. The chart plots Cmax and AUC values, showing changes relative to a reference value of 1. Commentary on clinical recommendations such as dose adjustments and cautions are included alongside each interacting drug.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 02)

A PK fold change chart for venlafaxine hydrochloride showing the effects of various interacting drugs on analyte Cmax and AUC values with 90% confidence intervals. The x-axis represents change relative to the reference value, while recommendations include dose adjustments, avoiding use, or no restrictions for drugs like ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 03)

A scatter plot chart illustrating pharmacokinetic changes (Cmax and AUC) of venlafaxine and its ODV metabolite across special populations and conditions such as hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender. The x-axis displays change relative to a reference value, with recommendations for dose adjustments listed for specific populations.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (E5d724aa Bc22 4503 B0e0 87b3b1d4a77e 04)

Chemical structure of venlafaxine hydrochloride showing the arrangement of carbon, hydrogen, nitrogen, oxygen atoms, and the hydrochloride component, with the molecular groups and bonds clearly depicted in a standard chemical diagram format.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.